SN Trading Analysis - 10/26/2026 12:39 PM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge context for SN (SANUWAVE Health, a regenerative medicine / wound-care name):

• SN has historically been a low-float micro-cap with periodic POS pilot-site expansions and CMS reimbursement clarifications driving sharp moves.
• No confirmed near-term earnings date was retrievable from the embedded data; fiscal year end is listed as 2025-12-01, suggesting annual reporting risk/eventuality outside the 25-day window.
• Broader small-cap biotech sentiment has been sensitive to rate-path expectations and dilutive raise headlines, which can amplify SN's 1.66 beta.
• Options flow in the embedded data shows 100% call conviction (Delta 40-60 only), which may reflect a catalyst-specific positioning event not captured in public headlines.

News context is separated from the strict data analysis below, which is derived entirely from the embedded JSON.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for SN:

• Trailing P/E: 39.80; Trailing EPS: 4.93 — valuation is elevated versus broad-market averages but typical of small-cap med-tech with speculative growth pricing.
• Market Cap: $27,919,421,680.00; Shares Outstanding: 140,872,000.00; Institutional Ownership: 50.61%.
• Dividend Yield: 0.00%; no dividend distribution (ex-dividend 2023-11-30, rate null).
• Beta: 1.66 — high systematic risk relative to market.
• 52-Week High: 200.39; 52-Week Low: 83.12 — current price near the top of annual range.
• Historical Volatility: 34.25%; Average Volume: 1,153,000.00.
• PEG Ratio, Forward P/E, Profit Margins, ROE, Debt/Equity, Free Cash Flow, Revenue Growth, and Analyst Target Price are all null/unavailable in the data.

Fundamentally, the data shows a high-multiple, non-revenue-disclosed, zero-yield small cap with elevated beta. This diverges from the strong technical uptrend and 100% call-options sentiment, where price is near 52-week highs with no fundamental confirmation of growth in the embedded set.

Current Market Position

From the embedded data, the current price (indicators calculated_at 2026-10-26) is 197.58. Daily close on 2026-10-23 was 197.58 (open 198.00, high 199.63, low 194.72, volume 615,000). Minute bars for 2026-10-26 show price oscillating 197.44 to 198.37, ending at 198.19 at 12:10.

Intraday momentum (last 5 minute bars 11:50–12:10) shows a lift from 197.44 to 198.19, suggesting mild recovery off the 197.44 low within a narrow range. Total minute bars: 51. Volume on 10-26 midday bars is light (4,000–5,500 per bar) vs 20-day avg 720,831 daily.

Technical Analysis

SMA alignment is bullish: price (197.58) > SMA 5 (196.84) > SMA 20 (187.95) > SMA 50 (181.02), no bearish crossover. RSI 63.92 shows moderate bullish momentum, not overbought (>70). MACD histogram positive (1.14) confirms bullish momentum. Bollinger Bands: price near upper band (200.78), upper band expansion intact. 30-day range high 200.38, low 158.82; current price is ~96% up the range. ATR 6.26 implies daily movement capacity of ~3.2%.

True Sentiment Analysis (Delta 40-60 Options)

From SN_options_20261026_1238.json (methodology: Delta 40-60 only):

Call Volume: $22,410.00 (100.00%) Put Volume: $0.00 (0.00%) Total: $22,410.00

• Call contracts: 14; Put contracts: 0; Call trades: 3; Put trades: 0.
• Sentiment: Bullish; total options analyzed 520, true sentiment options 3 (filter ratio 0.60%).

Pure directional positioning shows exclusive call conviction, suggesting near-term upside expectations. No divergence from technicals (both bullish), though low sample (3 trades) limits statistical weight. This is the only sentiment source; no X posts were retrieved.

Key Price Levels (Observational Only)